PTJ
AUXL

Paul Tudor Jones’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Paul Tudor Jones’s Portfolio AUXL Stock Details AUXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-10,900
Closed -$296K – 1474
2014
Q1 		$296K Sell
10,900
-21,100
-66% -$560K 0.01% 823
2013
Q4 		$663K Sell
32,000
-7,500
-19% -$141K 0.03% 379
2013
Q3 		$719K Sell
39,500
-5,000
-11% -$90.3K 0.03% 198
2013
Q2 		$740K Buy
+44,500
New +$711K 0.06% 184

Other funds holding AUXL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Paul Tudor Jones's AUXL Position: Q2 2014 in Review

Paul Tudor Jones sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q2 2014, closing a stake of 10,900 shares — an estimated $296K sold.

Paul Tudor Jones first reported a position in AUXL in Q2 2013 and held it in 4 quarters. The position peaked at $740K in Q2 2013. 152 funds tracked by Wall St. Rank hold AUXL as of Q2 2014.

  • Paul Tudor Jones reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q2 2014 after selling out during the quarter.
  • Paul Tudor Jones sold 10,900 AUXILIUM PHARAMCEUTICALS INC shares in Q2 2014, an estimated $296K.
  • Paul Tudor Jones first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 4 quarters.
  • Paul Tudor Jones's AUXILIUM PHARAMCEUTICALS INC position peaked at $740K in Q2 2013.
  • 152 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q2 2014.

Based on Tudor Investment Corp's 13F filing for Q2 2014, filed 14 Aug 2014.